Delcath Systems (DCTH) EBIT Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.62% |
| Dec 31, 2025 | 20.74% |
| Sep 30, 2025 | 39.98% |
| Jun 30, 2025 | 21.12% |
| Mar 31, 2025 | 16.29% |
| Dec 31, 2024 | 21.70% |
| Sep 30, 2024 | 25.73% |
| Jun 30, 2024 | 1.06% |
| Mar 31, 2024 | -12.62% |
| Dec 31, 2023 | -8.03% |
| Sep 30, 2023 | -12.75% |
| Jun 30, 2023 | -5.59% |
| Mar 31, 2023 | -2.10% |
| Dec 31, 2022 | -10.70% |
| Sep 30, 2022 | -12.05% |
| Jun 30, 2022 | -15.57% |
| Mar 31, 2022 | -14.64% |
| Dec 31, 2021 | -1.22% |
| Sep 30, 2021 | -7.23% |
| Jun 30, 2021 | -10.75% |
| Mar 31, 2021 | -14.21% |
| Dec 31, 2020 | -10.54% |
| Sep 30, 2020 | -6.41% |
| Jun 30, 2020 | -3.34% |
| Mar 31, 2020 | -6.47% |
| Dec 31, 2019 | -6.68% |
| Sep 30, 2019 | -1.97% |
| Jun 30, 2019 | 6.91% |
| Mar 31, 2019 | -2.32% |
| Dec 31, 2018 | -6.81% |
| Sep 30, 2018 | 2.87% |
| Jun 30, 2018 | 10.46% |
| Mar 31, 2018 | 5.96% |
| Dec 31, 2017 | 16.76% |
| Sep 30, 2017 | 17.59% |
| Jun 30, 2017 | 21.38% |
| Mar 31, 2017 | 21.96% |
| Dec 31, 2016 | -17.86% |
| Sep 30, 2016 | -19.01% |
| Jun 30, 2016 | -18.83% |
| Mar 31, 2016 | -19.56% |